Particular nations contain a "substantially comparable" catch-all clause of their drug law, which include New Zealand and Australia. This incorporates 6-APB since it is analogous in chemical framework to The category A drug MDA, that means 6-APB could possibly be seen like a controlled substance analogue in these jurisdictions.[19]Initially develop